Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome

Area of Science:

• Cardiovascular Science
• Metabolic Disease Research
• Inflammation Biology

Background:

• Atherosclerosis pathogenesis involves inflammation, with key roles for chemokines like monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8).
• A shared inflammatory basis is proposed for type 2 diabetes, metabolic syndrome, and atherosclerosis.
• Peripheral inflammatory markers in metabolic syndrome warrant investigation regarding lifestyle interventions.

Purpose of the Study:

• To investigate the impact of physical exercise and pravastatin on peripheral inflammation markers in metabolic syndrome patients.
• To assess the efficacy of a 12-week intervention on inflammatory profiles.
• To explore potential links between inflammatory markers and visceral fat changes.

Main Methods:

• An unmasked, randomized 2x2 factorial trial was conducted over 12 weeks.
• Participants with metabolic syndrome were assigned to exercise and/or pravastatin groups.
• Peripheral blood samples were analyzed for inflammatory markers MCP-1 and IL-8.

Main Results:

• Combined exercise groups showed significant reductions in MCP-1 (48 pg/ml, P=0.04) and IL-8 (1.0 pg/ml, P=0.007) compared to non-exercise groups.
• Significant reductions in MCP-1 (33%) and IL-8 (13%) were observed from baseline.
• Changes in MCP-1 levels correlated significantly with changes in visceral fat (r=0.41, P=0.02).

Conclusions:

• Physical exercise demonstrates a potential protective effect in metabolic syndrome, partly by suppressing inflammation.
• Exercise interventions may modulate key inflammatory pathways implicated in atherosclerosis.
• Targeting inflammation through exercise could be a strategy for managing metabolic syndrome and its cardiovascular risks.